Trends in cancer mortality in Switzerland, 1980–2001
- 1 February 2006
- journal article
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 15 (1) , 1-9
- https://doi.org/10.1097/01.cej.0000186638.35119.88
Abstract
Trends in cancer mortality in Switzerland were analysed over the period 1980–2001, on the basis of the World Health Organization database. Appropriately developed correction factors were utilized for the period before 1995, to allow for spurious trends introduced by the change between the 8th and the 10th revisions of the ICD. Steady declines in cancer mortality were observed, particularly from the mid-1980s onwards. Over the last decade, the fall in overall age-standardized (world standard) cancer mortality was 11.1% in men (from 158.1 in 1990–1991 to 140.6/100 000 in 2000–2001) and 7.6% in women (from 91.6 to 84.7/100 000), and the decline was larger in truncated rates from 35 to 64 years (−18.0 and −9.7%). In men, all major tobacco and alcohol neoplasms have declined until the late 1990s but have levelled off over the last few years, reflecting recent trends in alcohol and tobacco consumption. The fall in male lung cancer mortality was 20% over the last decade (from 42.9 to 34.3/100 000). In contrast, lung cancer mortality in women has steadily increased by 38% between 1981 and 1991 and by 47% between 1991 and 2001, to reach 10.7/100 000 at all ages and 18.3 at age 35 to 64, due to increased prevalence of smoking in subsequent generations of Swiss women. Other sites showing substantial declines include stomach and colorectum in both sexes, (cervix) uteri and breast in women. Likewise, prostate cancer showed modest favourable trends after 1995. Steady declines were observed for leukaemias, Hodgkin's disease and testicular cancer, namely, the neoplasms most influenced by therapeutic improvements, while trends in lymphomas and myeloma showed no clear pattern.Keywords
This publication has 43 references indexed in Scilit:
- Mortality from cancer in relation to smoking: 50 years observations on British doctorsBritish Journal of Cancer, 2005
- Treatment of Axillary Lymph Node-Negative, Estrogen Receptor-Negative Breast Cancer: Updated Findings From National Surgical Adjuvant Breast and Bowel Project Clinical TrialsJNCI Journal of the National Cancer Institute, 2004
- Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off?Melanoma Research, 2004
- The cervical cancer epidemic that screening has prevented in the UKThe Lancet, 2004
- Cancer mortality in Europe, 1995–1999, and an overview of trends since 1960International Journal of Cancer, 2004
- Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in ScandinaviaInternational Journal of Cancer, 2003
- Cervical cancer mortality in young women in EuropeEuropean Journal Of Cancer, 2000
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Cancer mortality in Switzerland, 1990–1994International Journal of Public Health, 1997